Related Experiment Video
Updated: Jul 13, 2026

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
[Cytology and immunophenotype feautures of 80 acute myeloid leukemia]
Emna Gouider1, Sameh Ayari, Selma Bouhoula
1Service d'Hématologie Biologique, l'Hopital Aziza Othmana, Tunis.
Insights
This study correlates cytology and immunophenotype in 80 acute myeloid leukemia (AML) cases. Specific CD marker expressions are linked to AML subtypes, aiding in diagnosis and understanding disease characteristics.
Area of Science:
- Hematology
- Oncology
- Clinical Pathology
Background:
- Acute myeloid leukemia (AML) diagnosis relies on clinical and biological features.
- Cytology and immunophenotyping are crucial for AML classification.
- Understanding subtype-specific markers improves diagnostic accuracy.
Purpose of the Study:
- To correlate cytological and immunophenotypic findings in 80 AML cases.
- To identify specific immunophenotypic markers associated with different AML subtypes.
- To explore the diagnostic utility of CD markers in AML.
Main Methods:
- Diagnosis of 80 AML cases using cytology.
- Immunophenotypic analysis of AML subtypes.
- Statistical correlation between cytological and immunophenotypic data.
Main Results:
- Cytological diagnosis included AML1 (21), AML2 (23), AML3 (12), AML4 (2), AML5 (18), and AML6 (3).
- CD19 and CD56 expression correlated significantly with AML with t(8;21).
- Concomitant negativity of CD34 and HLA-DR distinguished AML3.
Conclusions:
- Immunophenotype and cytology are complementary in AML diagnosis.
- Specific CD marker expressions are valuable for identifying AML subtypes.
- Further research is needed to establish the prognostic value of CD markers in AML.
Abstract:
Acute myeloid leukemia (AML)'s diagnosis is clinical and biological. We report here 80 AML with cytology and immunophenotype features to establish correlations. 21 AML1, 23 AML2, 12 AML3, 2 AML4, 18 AML5 and 3 AML6 were diagnosed by cytology. Only one case of AML0 was diagnosed by immunophenotype. Myelogysplasia is present in 29.8% cases. CD19 and CD56 expression was significantly associated to AML +t(8;21). Additionally, concomitant negativity of CD34 and HLA-DR was discrimininatif to AML3 diagnosis. Prognostic value to expression some CD needs time backwards.
More Related Videos
05:24Two Flow Cytometric Approaches of NKG2D Ligand Surface Detection to Distinguish Stem Cells from Bulk Subpopulations in Acute Myeloid Leukemia
Published on: February 21, 2021
07:38Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
Related Concept Videos
Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Classification of Leukocytes
Neutrophils are the most abundant type of granular leukocytes, comprising 50-70% of all leukocytes. They feature small, evenly distributed granules and a...
Differentiation of Common Myeloid Progenitor Cells